Erratum: Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion (Neuropsychopharmacology (2006) 31 (2264-2272) DOI: 10.1038/sj.npp.1301055);Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2264-2272

  Roiser, Jonathan P ^a,b   Blackwell, Andrew D ^a   Cools, Roshan ^c,d   Clark, Luke ^d   Rubinsztein, David C ^a   Robbins, Trevor W ^d   Sahakian, Barbara J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Biomedical Research Centre   (United Kingdom)

Author keywords

Acute tryptophan depletion; Depression; Motivation; Reward; Serotonin; Serotonin transporter gene (5 HTTLPR)

Indexed keywords

SEROTONIN TRANSPORTER; TRYPTOPHAN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BECK DEPRESSION INVENTORY; DEMOGRAPHY; DEPRESSION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MOTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT; RESPONSE TIME; REWARD; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; TASK PERFORMANCE; VOLUNTEER;

EID: 33748559016     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301084     Document Type: Erratum

References (63)

1. Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR et al (1995). Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berlin) 119: 179-185.
2. Aston-Jones G, Rajkowski J, Cohen J (1999). Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46: 1309-1320.
3. Bankson MG, Cunningham KA (2001). 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297: 846-852.
4. Beck AT, Ward CH, Medelson M, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
5. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
6. Brown P, Molliver ME (2000). Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci 20: 1952-1963.
7. Cannon CM, Bseikri MR (2004). Is dopamine required for natural reward? Physiol Behav 81: 741-748.
8. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
9. Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbins TW (2005). Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30: 1362-1373.
10. David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R et al (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25: 2586-2590.
11. De Deurwaerdere P, Stinus L, Spampinato U (1998). Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci 18: 6528-6538.
12. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47: 411-418.
13. Elliott R, Newman JL, Longe OA, Deakin JF (2003). Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study. J Neurosci 23: 303-307.
14. Elliott R, Rees G, Dolan RJ (1999). Ventromedial prefrontal cortex mediates guessing. Neuropsychologia 37: 403-411.
15. Everitt BJ, Cardinal RN, Parkinson JA, Robbins TW (2003). Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci 985: 233-250.
16. Fernstrom JD, Wurtman RJ (1972). Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178: 414-416.
17. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES et al (1998). Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 81: 58-63.
18. Furst P, Pollack L, Graser TA, Godel H, Stehle P (1990). Appraisal of four pre-column derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials. J Chromatogr 499: 557-569.
19. Gehring WJ, Willoughby AR (2002). The medial frontal cortex and the rapid processing of monetary gains and losses. Science 295: 2279-2282.
20. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55: 463-508.
21. Hallbus M, Magnusson T, Magnusson O (1997). Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study. Neurosci Lett 225: 57-60.
22. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF et al (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62: 146-152.
23. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400-403.
24. Harrison AA, Liem YT, Markou A (2001). Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25: 55-71.
25. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624.
26. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D et al (2005). Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 8: 20-21.
27. Hommer DW, Knutson B, Fong GW, Bennett S, Adams CM, Varnera JL (2003). Amygdalar recruitment during anticipation of monetary rewards: an event-related fMRI study. Ann N Y Acad Sci 985: 476-478.
28. Howell DC (2002). Statistical Methods for Psychology, 5th edn. Duxbury Press: London.
29. Knutson B, Adams CM, Fong GW, Hommer D (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21: RC159.
30. Knutson B, Fong GW, Bennett SM, Adams CM, Hommer D (2003). A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. Neuroimage 18: 263-272.
31. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
32. Leyton M, Ghadirian AM, Young SN, Palmour RM, Blier P, Helmers KF et al (2000). Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J Psychopharmacol 14: 284-287.
33. Li Q, Wichems C, Heils A, Lesch KP, Murphy DL (2000). Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci 20: 7888-7895.
34. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960-971.
35. Lott DC, Kim SJ, Cook Jr EH, de Wit H (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30: 602-609.
36. Markus CR, Olivier B, de Haan EH (2002). Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 75: 1051-1056.
37. Markus R, Panhuysen G, Tuiten A, Koppeschaar H (2000). Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress. Physiol Behav 70: 333-342.
38. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF et al (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
39. Merali Z, McIntosh J, Anisman H (2004). Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology 29: 1409-1418.
40. Minabe Y, Emori K, Ashby Jr CR (1996). The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study. Synapse 22: 46-53.
41. Minabe Y, Shirayama Y, Hashimoto K, Routledge C, Hagan JJ, Ashby Jr CR (2004). Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 52: 20-28.
42. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J et al (2002). Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7: 213-216.
43. Naranjo CA, Tremblay LK, Busto UE (2001). The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 25: 781-823.
44. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59: 613-620.
45. O'Doherty JP (2004). Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr Opin Neurobiol 14: 769-776.
46. Reist C, Mazzanti C, Vu R, Tran D, Goldman D (2001). Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet 105: 363-368.
47. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28: 153-162.
48. Roiser JP, Cook LJ, Cooper JD, Rubinsztein DC, Sahakian BJ (2005). Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users. Am J Psychiatry 162: 609-612.
49. Sasaki-Adams DM, Kelley AE (2001). Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25: 440-452.
50. Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (1992). 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223: 65-74.
51. Schultz W, Tremblay L, Hollerman JR (2000). Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 10: 272-284.
52. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet 127B: 85-89.
53. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3: 508-511.
54. Smith GS, Lotrich FE, Malhotra AK, Lee AT, Ma Y, Kramer E et al (2004). Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 29: 2226-2234.
55. Smith KA, Fairburn CG, Cowen PJ (1997). Relapse of depression after rapid depletion of tryptophan. Lancet 349: 915-919.
56. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH (2004). Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 9: 433-441.
57. Spitzer MB, Gibbon M, Williams JBW (2002). Stuctured Clinical Interview for DSM-IV-TR, Research Version, Patient Edition. (SCID-I/P). Biometrics Research, New York State Biometrics Institute: New York.
58. Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ (2000). Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berlin) 150: 120-122.
59. Williams GV, Goldman-Rakic PS (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-575.
60. Yan QS (2000). Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res Bull 51: 75-81.
61. Yan QS, Yan SE (2001). Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418: 55-64.
62. Young SN, Smith SE, Pihl RO, Ervin FR (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berlin) 87: 173-177.
63. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535.